Delivery Order SPE2DB24D1034-SPE2DB24FVYY5
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $9,859.73 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 0.25-0.5 mg/dose pens. This delivery order contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $5,102.97, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The award, valued at $51,508.23, has an ultimate completion date of April 15, 2024. This order is being issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $10,190.52 and a period of performance through September 12, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $2,954.06 and a period of performance through March 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The $5,570.89 contract, which has an ultimate completion date of April 8, 2024, does not have a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, is also the holder of a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to provide a wide...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,103.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ozempic 0.25-0.5 mg/dose pens. The contract has a ceiling value of $2,612.34 and a period of performance through March 18, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that DLA has with Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $10,080.39, has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...